Tysabri (natalizumab) is a brand-name intravenous (IV) infusion. It’s prescribed for adults with Crohn’s disease or certain forms of multiple sclerosis. Tysabri has interactions with some ...
Sandoz and Polpharma Biologics have become the first companies to get FDA approval for a biosimilar of Biogen's blockbuster multiple sclerosis therapy Tysabri, after overcoming a bid by Biogen to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback